The estimated Net Worth of Life Sciences Viii, L.P.Top... is at least 3.1 百万$ dollars as of 9 January 2020. Life Top owns over 50,000 units of Entasis Therapeutics Inc stock worth over 2,846,897$ and over the last 5 years Life sold ETTX stock worth over 250,000$.
Life has made over 1 trades of the Entasis Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Life sold 50,000 units of ETTX stock worth 250,000$ on 9 January 2020.
The largest trade Life's ever made was selling 50,000 units of Entasis Therapeutics Inc stock on 9 January 2020 worth over 250,000$. On average, Life trades about 50,000 units every 0 days since 2020. As of 9 January 2020 Life still owns at least 1,299,953 units of Entasis Therapeutics Inc stock.
You can see the complete history of Life Top stock trades at the bottom of the page.
Over the last 6 years, insiders at Entasis Therapeutics Inc have traded over 348,925$ worth of Entasis Therapeutics Inc stock and bought 50,891,639 units worth 170,673,776$ . The most active insiders traders include Group Holdings (Sbs) Adviso...、Inc.Innoviva Strategic Oppo...、Holdings A/S Novo. On average, Entasis Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of 4,855,580$. The most recent stock trade was executed by Inc.Innoviva Strategic Oppo... on 8 July 2022, trading 19,270,476 units of ETTX stock currently worth 42,395,047$.
Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis' pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae infections), ETX0282CPDP (targeting Enterobacteriaceae infections) and ETX0462 (targeting Pseudomonas infections).
Entasis Therapeutics Inc executives and other stock owners filed with the SEC include: